Welcome to our dedicated page for Tenet Healthcare news (Ticker: THC), a resource for investors and traders seeking the latest updates and insights on Tenet Healthcare stock.
Tenet Healthcare Corp (THC) operates a national network of hospitals and ambulatory centers, delivering acute care and technology-driven healthcare solutions. This news hub provides investors and industry professionals with timely updates on corporate developments, financial performance, and operational milestones. Stay informed about strategic initiatives shaping this diversified provider's role in the evolving healthcare sector.
Access comprehensive coverage of Tenet's press releases including earnings reports, strategic alliances, facility expansions, and regulatory updates. Our curated collection simplifies tracking the company's market position while maintaining strict editorial neutrality. Key focus areas include hospital operations, ambulatory service growth, and Conifer Health Solutions' performance.
This resource serves both casual observers and professional analysts seeking unfiltered access to primary source materials. Bookmark this page for centralized updates on Tenet Healthcare's official communications and third-party analysis. Monitor industry trends and corporate announcements affecting this leading healthcare services organization.
Tenet Healthcare (NYSE: THC) has announced a definitive agreement to sell its 70% majority ownership in Brookwood Baptist Health in Birmingham to Orlando Health for $910 million in cash. The deal includes five hospitals and related operations, with after-tax proceeds of approximately $790 million. Tenet's Conifer Health Solutions will enter a new 10-year contract for revenue cycle management services. The transaction is expected to complete in fall 2024, subject to regulatory approvals. Tenet estimates a pre-tax book gain of $375 million from this deal. For the twelve months ended June 30, 2024, Tenet's equity interest in Brookwood Baptist Health generated $12 million in pre-tax income and $60 million in Adjusted EBITDA less non-controlling interest. Tenet has reaffirmed its FY24 Adjusted EBITDA Outlook.
Tenet Healthcare (NYSE: THC) reported strong Q2 2024 results, surpassing expectations. Key highlights include:
- Net income of $259 million or $2.64 per diluted share
- Adjusted EBITDA of $945 million, up 12.1% year-over-year
- Ambulatory Care Adjusted EBITDA of $447 million, up 20.8%
- New $1.5 billion share repurchase program authorized
The company raised its FY 2024 outlook, now expecting Adjusted EBITDA of $3.825-$3.975 billion and Free Cash Flow of $1.100-$1.350 billion. Strong performance was driven by volume and revenue growth, improved operating efficiency, and portfolio transformation.
Tenet Healthcare (NYSE: THC) will release its second quarter 2024 financial results on July 24, 2024, by 6:00 a.m. Central Time (CT).
This will be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time), which will be available via live webcast and audio archive on Tenet’s investor relations section of their website.
Tenet Healthcare (THC) will be participating in the BofA Securities 2024 Health Care Conference on May 14, 2024. Investors can access the live webcast and audio archive on Tenet's investor relations website.
Tenet Healthcare (Tenet) (NYSE: THC) reported strong financial results for the first quarter of 2024, exceeding guidance and raising their 2024 financial outlook. Key highlights include net income of $2.151 billion, adjusted diluted earnings per share of $3.22, and an increase in Consolidated Adjusted EBITDA by 23.1%. The company has shown growth in revenues, admissions, and profitability, attributing it to operational excellence and strategic decisions. Cash flows and debt reduction have also improved. Recent transactions include retiring senior notes and completing hospital sales, impacting future interest payments positively. The outlook for 2024 shows strong projections across segments.
FAQ
What is the current stock price of Tenet Healthcare (THC)?
What is the market cap of Tenet Healthcare (THC)?
